Oryen presale results are in, and they’re impressive. The crowd sale gained 120% for early holders, as opposed to TAMA and Big Eyes. This is an excellent result for a presale only in its fourth phase and has no cap on how much you can buy.
Tamadoge and Big Eyes could follow in Oryen’s success, but will they? Let’s look at what Oryen accomplished and see how Tamadoge and Big Eyes follow or fail behind it!
Oryen Presale Gains
The Oryen presale has gained an impressive 120% since its ICO debut. It is an excellent sign for the future of the project. Can TAMA or Big Eyes beat the rates offered by Oryen Presale?
Moreover, Oryen network has outstanding features like the 90% annual percentage yield (APY) and Auto-Compounding hourly rewards. However, TAMA and Big Eyes are working hard to outperform the Oryen network. If they cannot match these rates, then there may be a little more time left before prices begin to drop again due to market saturation.
The best course of action would be to watch these projects closely to see if they can offer rates similar to that of Oryen’s presale gains. Big Eyes should also consider exploring some other opportunities as well. However, TAMA is also experiencing price increments along with the rise in listings.
Can TAMA and Big Eyes Outperform Oryen?
The Oryen presale has already gained 120% in value since the start of its ICO. However, TAMA and Big Eyes have yet to show any signs of slowing down, if anything, they’ve demonstrated a commitment to their original timelines and roadmaps.
With that in mind, both coins are a good choice in addition to Oryen due to their pedigree and institutional support. As we move into 2023, traders should watch closely how all three coins fare.
Join presale: https://presale.oryennetwork.io/register
Disclaimer: This is a sponsored article, and views in it do not represent those of, nor should they be attributed to, ZyCrypto. Readers should conduct independent research before taking any actions related to the company, product, or crypto projects mentioned in this piece; nor can this article be regarded as investment advice.